|
Name |
muyocopronol B
|
Molecular Formula | C38H68O11 | |
IUPAC Name* |
1,2,4,5,6-pentahydroxyhexan-3-yl18-ethyl-3,7,11,15-tetrahydroxy-2,6,8,10,12,14,16,20-octamethyldocosa-4,8,12,16-tetraenoate
|
|
SMILES |
CCC(C)CC(C=C(C)C(O)C(C)C=C(C)C(O)C(C)C=C(C)C(O)C(C)C=CC(O)C(C)C(=O)OC(C(O)CO)C(O)C(O)CO)CC
|
|
InChI |
InChI=1S/C38H68O11/c1-11-21(3)15-29(12-2)18-27(9)35(46)26(8)17-25(7)34(45)24(6)16-23(5)33(44)22(4)13-14-30(41)28(10)38(48)49-37(32(43)20-40)36(47)31(42)19-39/h13-14,16-18,21-22,24,26,28-37,39-47H,11-12,15,19-20H2,1-10H3/b14-13+,23-16+,25-17+,27-18+/t21?,22-,24-,26-,28+,29?,30+,31+,32+,33-,34-,35-,36+,37+/m0/s1
|
|
InChIKey |
LNNCBGCUNXQLNQ-PCMLKGJXSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 700.95 | ALogp: | 2.8 |
HBD: | 9 | HBA: | 11 |
Rotatable Bonds: | 23 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 208.4 | Aromatic Rings: | 0 |
Heavy Atoms: | 49 | QED Weighted: | 0.056 |
Caco-2 Permeability: | -5.046 | MDCK Permeability: | 0.00008850 |
Pgp-inhibitor: | 0.908 | Pgp-substrate: | 0.996 |
Human Intestinal Absorption (HIA): | 0.978 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.794 |
Blood-Brain-Barrier Penetration (BBB): | 0.104 | Plasma Protein Binding (PPB): | 77.27% |
Volume Distribution (VD): | 0.791 | Fu: | 4.52% |
CYP1A2-inhibitor: | 0.012 | CYP1A2-substrate: | 0.049 |
CYP2C19-inhibitor: | 0.001 | CYP2C19-substrate: | 0.075 |
CYP2C9-inhibitor: | 0 | CYP2C9-substrate: | 0.18 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.06 |
CYP3A4-inhibitor: | 0.122 | CYP3A4-substrate: | 0.229 |
Clearance (CL): | 3.36 | Half-life (T1/2): | 0.082 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.19 |
Drug-inuced Liver Injury (DILI): | 0.954 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.018 | Maximum Recommended Daily Dose: | 0.002 |
Skin Sensitization: | 0.003 | Carcinogencity: | 0.003 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.004 |
Respiratory Toxicity: | 0.002 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005725 | 0.718 | D02KFP | 0.290 | ||||
ENC005723 | 0.700 | D0B8SY | 0.278 | ||||
ENC005021 | 0.299 | D0RQ2W | 0.216 | ||||
ENC005126 | 0.266 | D01OIL | 0.202 | ||||
ENC004454 | 0.252 | D09MXS | 0.198 | ||||
ENC005667 | 0.245 | D0P7EK | 0.198 | ||||
ENC002304 | 0.238 | D02DJS | 0.181 | ||||
ENC003294 | 0.236 | D06HZY | 0.180 | ||||
ENC005668 | 0.233 | D0VM8K | 0.175 | ||||
ENC005666 | 0.233 | D0T6VD | 0.175 |